Treatment of aspergillus infections with thymosin alpha 1

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/16 (2006.01)

Patent

CA 2520400

A method for treating a human infected with Aspergillus by using thymosin alpha 1 as an immuno-stimulator in activating dendritic cells. The method is particularly useful in preventing an infection by Aspergillus in an immuno- compromised host being treated with a bone marrow transplantation.

L'invention concerne une méthode de traitement d'un être humain infecté par Aspergillus au moyen de thymosine alpha 1, en tant qu'immuno-stimulateur, dans l'activation de cellules dendritiques. Ladite méthode est, notamment, utilisée dans la prévention d'une infection par Aspergillus d'un hôte au système immunitaire compromis qui suit un traitement de transplantation de moelle osseuse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of aspergillus infections with thymosin alpha 1 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of aspergillus infections with thymosin alpha 1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of aspergillus infections with thymosin alpha 1 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1524753

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.